Fundraising FoxMC Healthcare Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Silence Therapeutics is a biotechnology company that discovers and develops short interfering RNA (siRNA) molecules designed to reduce the production of disease-associated proteins through the natural mechanism of RNA interference, with its proprietary mRNAi GOLD platform targeting specific genes in the liver for rare and common diseases.
BiotechLondon
Craig Tooman(Executive Officer)inGiles Campion(Executive Officer)Mark Rothera(Executive Officer, Director)inBarbara Ruskin(Executive Officer)
BoardJames Ede-Golightly(Director)Alistair Gray(Director)
Co-investorsForesite CapitalNextech InvestVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.